UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through two separate detection systems. In mice, a single dose controlled cancer and extended survival while avoiding a dangerous complication associated with donor-derived T-cell therapies.
Source: https://www.sciencedaily.com/releases/2 ... 231723.htm
-
Translation